Video
:quality(75)/cdn.jwplayer.com/v2/media/7pbVdk9C/poster.jpg)
Duración: 00:58
Estados Unidos aprueba el primer tratamiento contra el alzheimer
La Administración de Medicinas y Alimentos de Estados Unidos (FDA, por sus siglas en inglés) aprobó el uso del fármaco experimental Aducanumab para las fases tempranas de la enfermedad de Alzheimer. Fuente: [TV Perú]
- Redacción Trome
- 8 jun 2021, 08:34 p.m.
- Duración: 00:58
PLAYLIST
:quality(75)/cdn.jwplayer.com/v2/media/7pbVdk9C/poster.jpg)
Estados Unidos aprueba el primer tratamiento contra el alzheimer
:quality(75)/cdn.jwplayer.com/v2/media/VYBtNakX/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/o1KPg1hs/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/X6UGs2uP/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/qVhbOeGW/poster.jpg)
Lo último en Mundo
:quality(75)/cdn.jwplayer.com/v2/media/0Iveihj3/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/lupTafqG/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/2pfQ89VL/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/E6E7X5OSINHRDOYZMUZLR5JEJA.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/xzRAq8rj/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/2KPoyjcw/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/L7JzIO0g/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/Z7DBQ3HH2BC7DHDMJD4FEIM5IU.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/9i56j82w/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/pFlybVbr/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/ghAS5oCu/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/Sm0klgLl/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/Wit3VgMz/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/3RWZ3FCv/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/OdxLKN5g/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/twHKkx1J/poster.jpg)